270 related articles for article (PubMed ID: 20553082)
1. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.
Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
[TBL] [Abstract][Full Text] [Related]
4. Association of serum retinol and carotenoids with insulin-like growth factors and insulin-like growth factor binding protein-3 among control subjects of a nested case-control study in the Japan Collaborative Cohort Study.
Suzuki K; Ito Y; Hashimoto S; Kawado M; Inoue T; Ando M; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():29-35. PubMed ID: 20553078
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between risk of biliary tract cancer and circulating IGF (Insulin-like Growth Factor) -I, IGF-II or IGFBP-3 (IGF-binding Protein-3): A nested case-control study in a large scale cohort study in Japan.
Yagyu K; Kikuchi S; Lin Y; Ishibashi T; Obata Y; Kurosawa M; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():63-7. PubMed ID: 20553084
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
10. Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): A large-scale cross-sectional study in the Japan Collaborative Cohort study.
Wakai K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():23-7. PubMed ID: 20553077
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factors and breast cancer risk in Chinese women.
Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
[TBL] [Abstract][Full Text] [Related]
15. Associations of food and nutrient intakes with serum IGF-I, IGF-II, IGFBP-3, TGF-b1, total SOD activity and sFas levels among middle-aged Japanese: the Japan Collaborative Cohort study.
Maruyama K; Iso H; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():7-22. PubMed ID: 20553076
[TBL] [Abstract][Full Text] [Related]
16. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
[TBL] [Abstract][Full Text] [Related]
17. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.
Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A;
Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
20. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]